Business Description
Clover Health Investments Corp
NAICS : 525120
SIC : 6324
Description
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.1 | |||||
| Equity-to-Asset | 0.21 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -0.1 | |||||
| Beneish M-Score | 6.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.72 | |||||
| 9-Day RSI | 17.72 | |||||
| 14-Day RSI | 24.51 | |||||
| 6-1 Month Momentum % | -26.86 | |||||
| 12-1 Month Momentum % | -62.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 1.16 | |||||
| Cash Ratio | 0.32 | |||||
| Days Payable | 3.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -0.72 | |||||
| Operating Margin % | -20.38 | |||||
| Net Margin % | -15.55 | |||||
| ROE % | -92.38 | |||||
| ROA % | -25.52 | |||||
| ROIC % | -47.05 | |||||
| ROC (Joel Greenblatt) % | -5217.12 | |||||
| ROCE % | -60.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.32 | |||||
| PB Ratio | 2.02 | |||||
| Price-to-Tangible-Book | 2.02 | |||||
| EV-to-EBIT | -0.97 | |||||
| EV-to-Forward-EBIT | -2.14 | |||||
| EV-to-EBITDA | -0.98 | |||||
| EV-to-Forward-EBITDA | -2.25 | |||||
| EV-to-Revenue | 0.16 | |||||
| EV-to-Forward-Revenue | 0.1 | |||||
| EV-to-FCF | -2.24 | |||||
| Price-to-Net-Current-Asset-Value | 3.83 | |||||
| Earnings Yield (Greenblatt) % | -102.01 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLOV
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,580.278 | ||
| EPS (TTM) ($) | -0.858 | ||
| Beta | 0 | ||
| Volatility % | 75.45 | ||
| 14-Day RSI | 24.51 | ||
| 14-Day ATR ($) | 0.150728 | ||
| 20-Day SMA ($) | 2.26 | ||
| 12-1 Month Momentum % | -62.84 | ||
| 52-Week Range ($) | 1.79 - 8.58 | ||
| Shares Outstanding (Mil) | 477.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clover Health Investments Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clover Health Investments Corp Analysis
Share your researchHeadlines
See More
No news.